these kinds of changes in primary visual cortex. Moreover, although several studies have not observed strong BOLD signal enhancement in areas higher than V1, one study found enhancement in not only early visual areas but also the parietal cortex, suggesting the involvement of higher areas in perceptual learning.
The third approach is to combine measures of brain activity and behavior in non-human subjects, typically monkeys. Several influential studies identified changes in primary auditory and somatosensory cortices of monkeys that had been trained on discrimination tasks in those modalities. Similar changes have been found in the visual pathway, although changes found in primary visual cortex were small relative to those found in auditory and somatosensory cortex. A primary challenge for these kinds of studies is how exactly to relate neural and behavioral changes. A recent study exploited extensive prior work relating single-neuron activity in multiple brain regions to behavior on a visual motion directiondiscrimination task to show that, in monkeys learning the task, visual motion processing changed in a sensory-motor but not a sensory area. This work established the first evidence from single-unit studies for perceptual learning-related changes well beyond sensory cortex, in areas that interpret stimuli to form perceptual judgments.
What are the important outstanding questions? Many of the most basic questions about perceptual learning remain unanswered, particularly those that concern the underlying neural mechanisms. Neural correlates have been identified for only a small fraction of behavioral perceptual learning phenomena. Do these generalize to other tasks? If not, what other mechanisms are used? How can the discrepancies between results from human and animal studies be resolved? Moreover, previous results have been primarily correlative: what are the neural changes that play a causal role in perceptual learning? Answering this question will require other techniques like the manipulation of neural activity during learning. Moreover, much more work is needed to relate identified changes in perceptual processing with cellular and synaptic mechanisms of plasticity.
Many questions also remain unanswered about the computational principles that govern perceptual learning. Many models have been proposed. For example, under some conditions perceptual learning is associated with the sharpening of tuning curves at or near the trained feature, to improve detectability or discriminability of that feature. Some models assume that perceptual learning occurs as a result of signal enhancement or noise reduction in the perceptual pathway. These improvements can be implemented by changes in connectivity between sensory and decision areas. Other models focus on the role of attention. However, it is still not known how to reconcile these different models with each other and with all of the perceptual learning-related behavioral and physiological phenomena. Are these models mutually exclusive and simply apply to different conditions? If so, what are those conditions? If not, do at least some of the models describe different aspects of the same phenomena? More systematic investigations of perceptual learning under different conditions will hopefully clarify these issues in the future.
Where can I find out more? Fahle, M. (2005) . Perceptual learning: specificity versus generalization. Curr. Opin. Neurobiol. 15, 154-160. Gilbert, C.D., Sigman, M., and Crist, R.E. (2001) .
The neural basis of perceptual learning. Neuron 31, 681-697. Karni, A., and Sagi, D. (1991 The numerous definitions of evolutionary novelties can generally be divided into two categories. One emphasizes function, essentially focusing on the origin of novel functional capabilities, such as flight or vision, while the other definitions are structural, emphasizing the developmental origin of novel body parts. We prefer the latter definition because it more specifically highlights the developmental genetic problems with the origin of novelties. For instance, one can define a novelty as a novel body part that is neither homologous to any body part in the ancestral lineage nor serially homologous to any other body part of the same organism. To define novelty using the homology concept may sound like replacing one poorly defined term by another. In recent years, however, homology has re-emerged as a core organizing principle in evolutionary developmental biology. Applied to morphological structures the term homology refers to quasi-independent, individualized body parts that have their own evolutionary history, i.e. are derived from the same body part in a common ancestor and which form lineages of descent with modification, as exemplified by the evolutionary history of tetrapod limbs and eyes. Thus, a novelty is a derived individualized body part. Examples include the autopod (hand, feet) of the tetrapod limb, petals in eudicot flowers, eyespots on butterfly wings, the hair and mammary glands in mammals and the feathers of birds (Figure 1 ). According to this view, a transformation of an existing individualized body part is not a novelty, regardless of how radical the transformation is. For instance, a bird wing is a transformed forelimb, i.e. it is homologous to the forelimb of the theropod dinosaurs, which were already highly individualized body parts. But, in spite of its novel function as a flight organ, the bird wing is not a novelty because it is directly homologous to the forelimbs of tetrapods. There is a distinction between the evolutionary processes that lead to character transformation (e.g. the evolution of the bird wing) and those that lead to the evolution of new characters (e.g. feathers) given this approach to evolutionary novelties. Thus, developmental genetic research into the origin of novelties must explain how body parts become developmentally individualized.
There are two basic modes of character origination: differentiation among serially repeated elements and de novo origination (Figure 2) . Differentiation occurs if a structure is present in more than one copy in an ancestral lineage and becomes transformed into a novel structure by modification and individualization of a subset of these repeated structures. An instructive example is the origin of the mammary gland, which Mivart used to challenge Darwin. Developmental and comparative evidence shows that mammary glands are derived from accessory glands associated with hair. During development, the mammary glands of female monotremes and marsupials arise from epidermal anlagen that are divided into three distinct buds. The primary bud gives rise to a hair follicle (the 'mammary hair'), while the secondary bud gives rise to the mammary gland and the tertiary bud gives rise to the sebaceous gland. In placental mammals, however, the mammary gland develops without an association with hair. Thus, the mammary gland is a novel individualized organ in placental mammals because it is evolutionarily and developmentally distinct from hair glands (Figure 2A) .
The second route to novelty, de novo origination, is best understood in the case of vertebrate skeletal characters ( Figure 2B ). For example, bird legs are characterized by an elongated tibia and a reduced fibula that has completely lost its contact with the tarsal joint. With the reduction of the fibula a novel skeletal element arose, the syndesmosis tibio-fibularis (STF), which connects the reduced fibula to the tibia ( Figure 2B ). The functional reason for the origin of the STF is that the proximal fibula is still the insertion point of an important muscle, the ilio-fibularis muscle. Thus, in the absence of a direct contact between the fibula and the tarsal joint the force from the ilio-fibularis muscle has to be compensated by another structure, the STF. The ontogeny of the STF follows the typical sequence of a pressure-induced ossification in a tendon. Consistent with this model, motility of the chick embryo starts at the time of the formation of the STF and paralysis leads to the loss of the STF ( Figure 2C ).
The study of evolutionary novelties
Individualized body parts result from the execution of organ-specific programs of gene expression during development. This organ-specific pattern of gene expression is initiated by a combination of signals that lead to the activation of a core set of transcription factors that controls the expression of genes that perform the physiological 'work' of the cell. It is the activation of these tissue-specific genes that gives the tissue a unique identity that is distinct from other tissues. The key for the developmental individuality of a body part is the network of genes that mediate between the initiating signals and the expression of organ specific genes. This core network has been called 'character identity network', or the 'core network'. A corollary of this view is that the origin of a novelty requires the evolution of a new gene regulatory network that integrates signals into a gene expression pattern unique to that organ. Thus, the study of evolutionary novelties starts with identifying the signals that trigger character-specific gene expression and the identification of the gene regulatory network that is activated by these signals.
The objective of the study of evolutionary novelties is to understand the molecular changes that produced this organ-specific gene regulatory network. These networks can sometimes be understood as modifications of ancestral regulatory networks. For instance, the gene regulatory network of butterfly eyespots resembles the network that determines the boundary between the anterior and the posterior wing compartments. There is also evidence that the eyespot network includes elements of the regulatory interactions creating the space between wing veins (A) Individualization of a serially repeated structure as exemplified by the differentiation of hairs into mammary glands. In monotremes and marsupials the gland develops from an epidermal anlage that grows into the underlying dermis and forms three distinct buds. The primary bud (1°) gives rise to the hair follicle, the secondary bud (2°) gives rise to the mammary gland and the tertiary bud (3°) gives rise to the sebaceous gland. In placental mammals, the mammary gland has gained developmental independence from hair (red bar) and develops directly without forming a hair follicle. (B) The de novo origination of a skeletal element in birds. In birds the fibula (stippled) of the lower leg is greatly reduced and no longer contacts the ankle. The fibula, however, is still the insertion point of the iliofibularis muscle (black structure). To compensate, the syndesmosis tibio-fibularis (STF) anchors the fibula to the tibiotarsus to direct the force from the iliofibularis. After Müller, G.B. and Streicher, J. (1989) Anat. Embryol. 179, 327-339. (C) The STF (blue) and its absence in an animal paralyzed during fetal development (arrow). After: Müller, G.B. (2003) Evol. Dev. 5, 56-60. and of the appendage-patterning network. Alternatively, networks can be assembled de novo. For example, the gene regulatory network critical for the development of the turtle carapace is unlikely to be homologous to any other network. While the ribs of other animals grow ventrally and fuse at the midline, in turtles, a signal from a unique signaling center, the carapacial ridge, diverts the growth of the ribs laterally. Originally it was thought that the carapacial ridge is a re-deployment of the gene regulatory network that directs the outgrowth of limb buds. However, detailed genetic investigations failed to identify the key regulatory genes in the carapacial ridge that are characteristic of the limb bud. Therefore, it is likely that the carapacial ridge arose from the de novo origination of a gene regulatory network than from the wholesale re-deployment of the limb network.
The bottom line for any study of evolutionary novelties is explaining the origin of the gene regulatory network that executes organ-specific gene expression. Whether these networks are modifications of ancestral gene regulatory networks, are assembled de novo, or assembled through some combination of recruitment of existing networks and de novo origination is an open empirical question.
Genomic processes and the origin of novelties
There is broad agreement that the vast majority of the genetic changes responsible for the evolution of morphology occur at pre-existing cis-regulatory elements. In addition, protein changes in enzymes and receptors in various pigment pathways have been found to be important for changes in coat color in mammals and flower color in plants. While there is ample evidence for the importance of cisregulatory elements in the evolution of morphology, it's questionable whether the amount and the kind of genetic change involved in the origin of novelties has been achieved by these small-scale changes. For example, comparative transcriptome data suggest that the expression of hundreds and even thousands of genes was reorganized during the evolution of a novel cell type in mammals. Furthermore, the evolution of novelties requires the integration of external signals into a new, stereotyped and cell-typespecific pattern of gene expression. There is increasing evidence that the evolution of novel characters involves genetic mechanisms other than mutations at existing cis-regulatory elements. Thus, the genetic mechanisms responsible for character origination may be different from the mechanics of character modification. In the following sections we discuss two mechanisms that are emerging as both vital for the origination of novel gene regulatory networks and distinct from the genetic basis of most character modifications: transposable element mediated network rewiring and the divergence of transcription factor function.
Transposable element driven network innovation
Classic early studies on the evolution of gene regulation suggested that transposable elements may have played an important role in the origin of novel gene regulatory networks ( Figure 3A ), but clear examples of novel networks originating from transposon-mediated network rewiring have remained elusive until recently. There is now increasing evidence that transposable elements can play a major role in the evolution of gene regulation. Transposable elements carry with them an array of transcription factor binding sites that, when integrated into the genome, can become either alternative promoters of nearby genes, new enhancers or even insulator elements. For example, the placenta-specific promoter of the primate CYP19 gene, the uterinespecific enhancer of prolactin ( Figure  3B ) and numerous binding sites for the Drosophila su(Hw) protein, a potent transcriptional insulator, are derived from transposable elements. Recent genome-wide studies have found that ~8% of human proximal promoters and at least 5.5% of conserved non-coding regions in mammals are derived from transposable elements, suggesting that they play an important role in shaping gene regulation.
Transcription factor divergence
The functional specificity of transcription factor proteins is partly determined by the DNAbinding domain, which mediates the interaction between transcription factors and their binding-sites. For many transcription factors, however, the affinity to its binding site is not strong enough to explain functional specificity. For these transcription factors, specificity is achieved through cooperative associations with other transcription factors or non-coding RNAs. The formation of these transcription factor complexes is a major mechanism that integrates converging signaling pathways into a unitary transcriptional response ( Figure 4A ). For example, the differentiation of endometrial stromal cells in preparation for pregnancy depends on integrating signals from the steroid hormones estrogen and progesterone and the PKA pathway through c-AMP. Each pathway signals to distinct transcription factors to In endometrial stromal cells, transcription of PRL is controlled by an enhancer (dPRL) that is derived from a transposable element (MER20) that invaded the mammalian genome at the time when invasive placentation has evolved. In primates, the non-coding exon 1a of PRL, which is only expressed in endometrial stromal cells, itself derives from another transposable element (MER39). mediate a specific transcriptional response. In the case of progesterone, the transcription factors are the progesterone receptor (PGR) and HoxA-11 while the proximate effector of PKA signaling is C/EBPb ( Figure  4B ). The activated transcription factors from both pathways cooperate to form a protein complex, and it is this complex that actively regulates target gene expression.
Given this mechanistic background it is not surprising that adaptive evolution of transcription factor proteins seems to be often associated with evolutionary novelties, but is rarely found to play a role in adaptive modifications of existing body parts. For example, the recruitment of the transcription factor HoxA-11 into the gene regulatory network of endometrial stromal cells was achieved through amino acid substitutions that allowed cooperative target-gene activation with FOXO1A ( Figure 4C ). Hence, it is misguided to assume that the genetic changes important for morphological evolution primarily occur in cis-regulatory elements while transcription factors play no, or only a minor role. The evolution of novel protein-protein interactions is likely to be an integral part of the origin of novelties because they play an essential role in coordinating the expression of target genes in response to multiple input signals in a way that cis-regulatory elements cannot.
Conclusions
One of the major challenges in biology is to explain the origin of morphological novelties; however, while novelties have long fascinated biologists, it is only recently that the tools required to explore the mechanistic basis of innovation have been developed and applied to the study of novelties. The study of evolutionary novelties entails a number of research questions that are irrelevant to the study of most adaptations or speciation. Most important among them is how did the gene regulatory network arise that endows a structure with the developmental individuality required to form a unique body part? Downstream of this general question are many other detailed ones: How do novel cis-regulatory elements arise? How is the cohesion of geneexpression output achieved? Is the mechanism of network innovation the same as divergence? And, are different kinds of phenotypic change biased so that they are realized more often through cis-regulatory or protein evolution? It is likely that the origination of novelties occurs through multiple genetic routes, but an important emerging theme is that large-scale network rewiring requires genome-wide changes, including transposable element invasion and transcription factor evolution.
